Dr. Mark Anthony Latina , MD
Ophthalmology • Reading, MA
20 Pondmeadow Dr Ste 203
Reading, MA 018673261
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on October 26, 2005; this date does not establish years in practice.
-
Published CMS data list 3,455 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- J7351 — Injection, bimatoprost, intracameral implant, 1 microgram: 770 service units.
- 92012 — Established patient problem focused exam of visual system: 758 service units.
- 92133 — Imaging of optic nerve: 369 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 18 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 4,239 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Timolol Maleate — 504 prescription fills, including refills.
- Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) — 388 prescription fills, including refills.
- Prednisolone Acetate — 351 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 45 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 70% of clinicians listed under Ophthalmology in Massachusetts (2024, 480 clinicians with data). Median for this group: 1,836. Middle half: 621 to 3,502.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 5,794 in 2020 to 3,455 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
20 Pondmeadow Dr Ste 203
Reading, MA 018673261
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 3 distinct group names: Andover Eye Associates Inc; Specialty Eye Consultants 2 Llc; Specialty Eye Consultants, Llc. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
University Of Connecticut School Of Medicine
1980
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
471 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $402,864 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $299,099 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
8,436 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$639,093 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $73,910.20 across 178 records.
By nature of payment (3 largest of 4)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $56,520.00 across 13 records.
- Travel and Lodging: $9,187.06 across 26 records.
- Food and Beverage: $5,978.14 across 137 records.
Reporting-company totals (3 largest of 16)
- Alcon Vision LLC: $35,735.62 across 58 records.
- ABBVIE INC.: $27,911.83 across 68 records.
- Sight Sciences, Inc.: $8,976.18 across 17 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
46 years (graduated 1980)
CMS Doctors and Clinicians data list 1980 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
May accept Medicare assignment
CMS data show this clinician may accept Medicare assignment. Clinicians who do not always accept assignment can decide case by case.
Ask the office before your visit. If a clinician does not accept assignment for a service, they can charge up to 15% more than the Medicare-approved amount, and you may be asked to pay the full amount at the visit.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Latina has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Latina as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Reading and Massachusetts
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 70% of clinicians listed under Ophthalmology in Massachusetts (2024, 480 clinicians with data). Median for this group: 1,836. Middle half: 621 to 3,502.
Too few clinicians listed under Ophthalmology in Reading have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 70% of clinicians listed under Ophthalmology in Massachusetts (2024, 480 clinicians with data). Median for this group: $193,068. Middle half: $60,397 to $416,557.
Too few clinicians listed under Ophthalmology in Reading have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 70% of clinicians listed under Ophthalmology in Massachusetts (2024, 480 clinicians with data). Median for this group: $143,381. Middle half: $41,538 to $304,079.
Too few clinicians listed under Ophthalmology in Reading have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Ophthalmology in Massachusetts (2024, 516 clinicians with data). Median for this group: 777. Middle half: 213 to 2,065.
Too few clinicians listed under Ophthalmology in Reading have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Ophthalmology in Massachusetts (2024, 516 clinicians with data). Median for this group: $59,749. Middle half: $7,822 to $215,537.
Too few clinicians listed under Ophthalmology in Reading have Medicare Part D data for 2024 to compare.
3 active clinicians are listed under Ophthalmology with a practice address in Reading, MA (786 in Massachusetts).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 40% from 5,794 in 2020 to 3,455 in 2024.
- 2020: 5,794
- 2021: 4,690
- 2022: 2,990
- 2023: 3,684
- 2024: 3,455
-
Medicare-allowed amount
Medicare-allowed amount decreased 38% from $648,219 in 2020 to $402,864 in 2024.
- 2020: $648,219
- 2021: $568,849
- 2022: $329,439
- 2023: $445,314
- 2024: $402,864
-
Paid by Medicare
Paid by Medicare decreased 38% from $480,623 in 2020 to $299,099 in 2024.
- 2020: $480,623
- 2021: $413,366
- 2022: $243,561
- 2023: $336,053
- 2024: $299,099
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 28% from 5,873 in 2020 to 4,239 in 2024.
- 2020: 5,873
- 2021: 5,653
- 2022: 4,653
- 2023: 4,579
- 2024: 4,239
-
30-day fills
30-day fills decreased 23% from 10,993 in 2020 to 8,436 in 2024.
- 2020: 10,993
- 2021: 10,843
- 2022: 9,136
- 2023: 9,018
- 2024: 8,436
-
Part D drug cost
Part D drug cost decreased 43% from $1,130,407 in 2020 to $639,093 in 2024.
- 2020: $1,130,407
- 2021: $1,084,965
- 2022: $915,791
- 2023: $829,702
- 2024: $639,093
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 241% from $21,646.05 in 2021 to $73,910.20 in 2025.
- 2021: $21,646.05
- 2022: $49,212.94
- 2023: $61,210.64
- 2024: $48,973.36
- 2025: $73,910.20
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 178 records totaling $73,910.20.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Alcon Vision LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Rocklatan | General | $6,500.00 |
| Alcon Vision LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Rhopressa | General | $6,500.00 |
| Alcon Vision LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Rocklatan | General | $6,045.00 |
| Alcon Vision LLC |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
Rhopressa | General | $5,500.00 |
| Sight Sciences, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
OMNI SURGICAL SYSTEM | General | $4,200.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $3,625.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XEN GLAUCOMA TREATMENT SYSTEM | General | $3,625.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $3,625.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $3,625.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $3,625.00 |
| Sight Sciences, Inc. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
OMNI SURGICAL SYSTEM | General | $3,500.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
XEN GLAUCOMA TREATMENT SYSTEM | General | $3,250.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
DURYSTA | General | $2,900.00 |
| Alcon Vision LLC |
Travel and Lodging
In-kind items and services
|
Rocklatan | General | $1,738.00 |
| Alcon Vision LLC |
Travel and Lodging
In-kind items and services
|
Rhopressa | General | $1,635.78 |
| Alcon Vision LLC |
Consulting Fee
Cash or cash equivalent
|
Rhopressa | General | $1,500.00 |
| Alcon Vision LLC |
Travel and Lodging
In-kind items and services
|
Rhopressa | General | $1,269.51 |
| Alcon Vision LLC |
Travel and Lodging
In-kind items and services
|
Rocklatan | General | $1,016.65 |
| Alcon Vision LLC |
Travel and Lodging
In-kind items and services
|
Rhopressa | General | $906.24 |
| ABBVIE INC. |
Travel and Lodging
In-kind items and services
|
XEN GLAUCOMA TREATMENT SYSTEM | General | $740.79 |
| ABBVIE INC. |
Consulting Fee
Cash or cash equivalent
|
DURYSTA | General | $725.00 |
| Alcon Vision LLC |
Travel and Lodging
In-kind items and services
|
Rocklatan | General | $309.86 |
| Alcon Vision LLC |
Travel and Lodging
Cash or cash equivalent
|
Rhopressa | General | $272.92 |
| Alcon Vision LLC |
Travel and Lodging
In-kind items and services
|
Rhopressa | General | $263.49 |
| Alcon Vision LLC |
Travel and Lodging
Cash or cash equivalent
|
Rhopressa | General | $230.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
J7351
Injection, bimatoprost, intracameral implant, 1 microgram
|
770 | 45 | $250.00 | $204.28 |
|
92012
Established patient problem focused exam of visual system
|
758 | 375 | $290.03 | $98.68 |
|
92133
Imaging of optic nerve
|
369 | 352 | $141.30 | $39.29 |
|
92250
Photography of the retina
|
366 | 346 | $206.59 | $40.47 |
|
92014
Established patient complete exam of visual system
|
325 | 310 | $361.46 | $138.65 |
|
92083
Exam of visual field with extended testing
|
261 | 251 | $279.67 | $70.23 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
143 | 123 | $221.92 | $98.81 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
102 | 87 | $367.89 | $139.14 |
|
66030
Injection of medication into eye
|
78 | 46 | $354.49 | $202.00 |
|
92134
Imaging of retina
|
58 | 47 | $145.69 | $44.10 |
|
92020
Exam of the internal drainage system of eye
|
56 | 55 | $85.71 | $29.32 |
|
65855
Laser repair to improve eye fluid flow
|
51 | 39 | $1529.41 | $273.68 |
|
68200
Injection into conjunctiva
|
27 | 13 | $350.00 | $45.55 |
|
76514
Ultrasound scan of cornea to determine thickness
|
25 | 25 | $50.00 | $11.60 |
|
66821
Removal of recurring cataract in lens capsule using a laser
|
22 | 22 | $1500.00 | $369.78 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
20 | 20 | $450.00 | $181.31 |
|
92004
New patient complete exam of visual system
|
12 | 12 | $414.58 | $163.79 |
|
92136
Measurement of corneal curvature and depth of eye
|
12 | 12 | $300.00 | $48.77 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Timolol Maleate | Timolol Maleate | 504 | 34,186 | $10,369.04 | 178 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 388 | 26,412 | $7,668.40 | 128 |
| Prednisolone Acetate | Prednisolone Acetate | 351 | 14,999 | $12,672.50 | 210 |
| Brimonidine Tartrate | Brimonidine Tartrate | 304 | 18,311 | $39,431.29 | 103 |
| Latanoprost | Latanoprost | 283 | 17,797 | $3,275.83 | 102 |
| Pilocarpine Hcl | Pilocarpine Hcl | 223 | 18,026 | $12,462.25 | 91 |
| Brinzolamide | Brinzolamide | 211 | 13,433 | $35,877.99 | 64 |
| Ofloxacin | Ofloxacin | 195 | 4,585 | $2,088.73 | 138 |
| Dorzolamide Hcl | Dorzolamide Hcl | 165 | 11,121 | $3,250.28 | 58 |
| Bromfenac Sodium | Bromfenac Sodium | 155 | 6,536 | $36,219.33 | 79 |
| Lumigan | Bimatoprost | 136 | 8,443 | $69,509.53 | 58 |
| Combigan | Brimonidine Tartrate/Timolol | 108 | 5,462 | $47,616.63 | 29 |
| Alphagan P | Brimonidine Tartrate | 80 | 6,024 | $40,531.50 | 33 |
| Rhopressa | Netarsudil Mesylate | 79 | 4,110 | $41,727.60 | 44 |
| Acetazolamide | Acetazolamide | 75 | 5,610 | $6,278.18 | 25 |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 61 | 3,771 | $8,944.09 | 27 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 60 | 2,853 | $922.85 | 33 |
| Prolensa | Bromfenac Sodium | 59 | 2,416 | $22,377.23 | 28 |
| Restasis | Cyclosporine | 57 | 3,750 | $75,839.86 | 26 |
| Erythromycin | Erythromycin Base | 56 | 741 | $692.62 | 30 |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 56 | 3,220 | $9,113.30 | 20 |
| Atropine Sulfate | Atropine Sulfate | 52 | 3,422 | $1,774.54 | 41 |
| Betaxolol Hcl | Betaxolol Hcl | 40 | 2,386 | $4,390.20 | 15 |
| Simbrinza | Brinzolamide/Brimonidine Tart | 39 | 2,618 | $13,377.39 | 13 |
| Azopt | Brinzolamide | 38 | 1,395 | $17,500.06 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20050331000018
MA
3274506720
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Specialty Eye Consultants, Llc
20 Pondmeadow Dr, Reading, MA 018673261
Phone: 7819429876
Andover Eye Associates Inc
138 Haverhill St, Andover, MA 018101501
Phone: 9784750705
Specialty Eye Consultants 2 Llc
20 Pondmeadow Dr, Reading, MA 018673261
Phone: 7818916377
Specialty Eye Consultants 2 Llc
607 N Ave, Wakefield, MA 018801322
Phone: 7816622216
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Ophthalmology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated October 26, 2005.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Ophthalmology Specialists in Reading
Healthcare providers in ReadingMailing Address
20 Pondmeadow Dr Ste 203
Reading, MA 018673261
Phone: 7819429876